John Mccormick

At InnovaHealth Partners, we believe in the power of medical device innovation to address large unmet surgical needs on a global scale, meaningfully enhancing patient outcomes and furthering value- and evidence-based delivery of care. Headquartered in New York City, our team of seasoned professionals has worked together for over 16 years and has $290 million of assets under management between its funds and co-investments while working to identify innovative, differentiated investment opportunities in the medical device sector. When combined with strong management, strategic insight and capital, the InnovaHealth portfolio companies unlock substantial value for all stakeholders. Each new investment at our firm is carefully selected and backed by extensive research. Our network of device company managers, physicians and consultants and our dedicated investigation of industry, scientific and financial developments impacting the medical device sector affords our firm unique access to information about the industry and its trends. Our research program generates ideas and plays a crucial role in our investments, strategy and sourcing, establishing us as a leader in medical device private equity. As an industry driven by innovation and shored up by favorable patient volume and demographics, medical devices remain the most compelling segment in healthcare. Our expertise and experience allow us to optimize financial return within this high-growth sector, but also to deliver on our commitment to improving patient outcomes and providing value throughout the healthcare system.